LIGAND PHARMACEUTICALS INCORPORATED

(NASDAQ:LGND)
  Sep 30, 2008 Jun 30, 2008 Mar 31, 2008 Dec 31, 2007
Cash Flow Statement
Cash At Beginning Of Period 76,812 76,812 158,401
Cash At End Of Period 29,177 59,543 76,812
Net Change In Cash And Cash Equivalents -47,635 -17,269 -81,589
Effect Of Exchange Rate Changes
Net Income Or Loss -10,362 -3,933 281,688
Cash From Operating Activities
Depreciation Expenses 548 298 1,706
Amortization Expenses -982 -491
Amortization Of Intangibles Expenses 909
Deferred Income Taxes
Operating Gains Or Losses -5,499 -7,826 1,787
Extraordinary Gains Or Losses
Increase Or Decrease In Receivables 11,537
Increase Or Decrease In Inventories 930
Increase Or Decrease In Prepaid Expenses
Increase Or Decrease In Other Current Assets
Increase Or Decrease In Payables 2,634 2,048 1,404
Increase Or Decrease In Other Current Liabilities -5,714 -4,409 -51,889
Increase Or Decrease In Other Working Capital
Other Non Cash Items 10 16 -17,814
Net Cash From Continuing Operations 5,995 4,898 -327,985
Net Cash From Discontinued Operations -13,370 -9,399 -97,727
Net Cash From Operating Activities
Cash From Investing Activities
Sale Of Property Plant And Equipment 40 322
Sale Of Long Term Investments
Sale Of Short Term Investments
Purchase Of Property Plant And Equipment -385 -196 -440
Acquisitions 8,058 8,058 310,139
Purchase Of Long Term Investments
Purchase Of Short Term Investments -58,858 -22,601 -25,565
Other Investing Changes Net -6 -50 39,265
Cash From Discontinued Investing Activities
Net Cash From Investing Activities -31,787 -5,777 343,837
Cash From Financing Activities
Issuance Of Debt 46 34 4,387
Issuance Of Capital Stock -911 -514 -39,919
Repayment Of Debt -1,613 -1,613 -39,610
Repurchase Of Capital Stock -252,557
Payment Of Cash Dividends
Net Other Financing Charges
Cash From Discontinued Financing Activities
Net Cash From Financing Activities -2,478 -2,093 -327,699